Introduction {#Sec1}
============

Patients with chronic heart failure (CHF) often develop breathing abnormalities, including various forms of oscillatory breathing patterns characterized by rises and falls in ventilation.[@CR2],[@CR22] Periodic breathing (PB) during sleep or wakefulness has been found to be a powerful predictor of poor prognosis in CHF patients.[@CR9] PB patterns can be classified into ventilation with apnea, commonly known as Cheyne--Stokes respiration (CSR), or ventilation without apnea.[@CR4],[@CR11] Recent studies report a PB prevalence as high as 70% in CHF patients.[@CR13] Moreover PB, and especially CSR, has been associated with increased mortality.[@CR3],[@CR7],[@CR14] Accurate risk stratification is crucial both for establishing prognosis and appropriate allocation of limited resources for advanced, but expensive, treatments such as heart transplantation.[@CR1] Physiological parameters for the characterization and detection of different breathing patterns have been suggested in a number of clinical studies.[@CR16],[@CR18] The patterns are influenced by the degree of wakefulness, posture, and physiological and mental activity.[@CR15]

There are multiple clinical predictors of outcome for heart failure patients such as the New York Heart Association (NYHA) classification stages, left ventricular ejection fraction, systolic arterial pressure, and peak VO~2~ at cardiopulmonary exercise testing, low exercise tolerance, arrhythmias, cardiothoracic ratio, and disturbances in the autonomic nervous system. Although these accepted risk indices perform well in the prediction of mortality due to disease progression, the prediction of sudden cardiac death (SCD) appears more problematic. In hospitalized, symptomatic CHF patients with high risk of all-cause mortality, death is often due to progressive pump failure. However, in ambulatory patients with less severe CHF, symptoms may be less obvious and death is more often sudden in nature. Therefore, it is important to identify mildly symptomatic CHF patients at risk for SCD. A combination of various risk markers that account for different information appears to be a better approach to predict the risk level in a heterogeneous CHF population. Thus, in view of the breathing abnormalities presented by CHF patients, we have focused on extracting relevant information from the respiratory pattern, which can be used to discriminate mildly symptomatic CHF patients from those at higher risk.

Normal breathing cycle lengths range from 3 to 5 s (i.e., 0.20--0.33 Hz). PB patterns have cycle lengths from 25 to 100 s (i.e., 0.01--0.04 Hz).[@CR15] However, the same patient often exhibits a mixture of breathing patterns, ranging from nonperiodic breathing (nPB), i.e., without cyclic modulation of ventilation, through mild PB to CSR patterns. The origin of the PB pattern is still a matter of debate among researchers. The respiratory modulation frequency appears to be essential for the understanding of periodic and nPB patterns in CHF patients. Our previous studies were focused on characterizing the frequency band determined by the peak of the power spectral density (PSD) associated with the envelope of the respiratory flow signal.[@CR5],[@CR6]

The aim of this study is to characterize the respiratory flow signal in CHF patients and healthy subjects using the envelope. Based on autoregressive (AR) power spectral analysis of the envelope, the relevant discriminant band (DB) is determined from the location of the modulation frequency peak, and characterized by a number of spectral parameters. This article expands considerably on the initial results obtained with this approach and presented by Garde *et al.*[@CR5],[@CR6]

Dataset {#Sec2}
=======

Respiratory flow signals were recorded from 35 healthy volunteers (23 females, 27 ± 7 years, respiratory frequency 15.5 ± 3.7 breaths/min) and 26 CHF patients (7 females, 65 ± 9 years, 19.6 ± 3.4 breaths/min) at Santa Creu i Sant Pau Hospital, Barcelona, Spain. All subjects were studied according to a protocol approved by the local Ethics Committee. The respiratory flow signals were acquired using a pneumotachograph, consisting of a Datex-Ohmeda monitor with a Validyne Model MP45-1-871 Variable-Reluctance Transducer (Validyne Corp., Northridge, CA, USA). The pneumotachograph was connected to a mask. The signals were recorded at 250 Hz sampling rate and 12 bit resolution.

Prior to data acquisition, a few minutes of adaptation were allowed in order to make the subjects feel comfortable with the mask. The respiratory flow signals were acquired during 15 min in both CHF patients and healthy subjects. All subjects were seated and remained awake throughout acquisition.

According to clinical criteria, the CHF patients were classified into two groups: 8 patients with PB patterns (one female, 71 ± 7 years, 18.4 ± 2.2 breaths/min, 71.4 ± 10.8 beats/min) and 18 patients with nPB pattern (five females, 62 ± 9 years, 22.5 ± 4.3 breaths/min, 76.2 ± 10.9 beats/min). Within the PB group, three patients were classified as CSR (one female, 68 ± 6 years, 21.7 ± 4.2 breaths/min, 66.0 ± 5.3 beats/min) and five patients as PB without apnea (no females, 73 ± 8 years, 23.0 ± 4.7 breaths/min, 81.0 ± 9.2 beats/min). nPB patients have 2--3 NYHA classification and PB patients have 3--4 NYHA classification. All patients show a decompensate heart activity. Figure [1](#Fig1){ref-type="fig"} illustrates the different flow patterns observed in CSR, PB, nPB patients, and a healthy subject.FIGURE 1Excerpts of respiratory flow signals from a (a) CSR patient, (b) PB patient, (c) nPB patient, and (d) healthy subject

For the 61 subjects, the respiratory frequency was found to range from 0.2 to 0.4 Hz, and the modulation frequency from 0.01 to 0.04 Hz. These frequency ranges are in good agreement with those earlier reported by Pinna *et al.*[@CR15]

Methods {#Sec3}
=======

Signal Preprocessing {#Sec4}
--------------------

The respiratory flow signal is preprocessed with respect to artifact reduction in order to ensure robust signal analysis. Such processing is essential as certain artifacts can be difficult to distinguish from a normal breath. Outlier samples are rejected whose amplitude fall below the 1st percentile or exceed the 99th percentile of the entire signal's amplitude histogram; the outliers are replaced with the proper percentile value corresponding to 1st or 99th percentile. Short-duration spike artifacts, not removed with the percentile test, are detected using an auxiliary signal which results from sampling rate decimation of the original flow signal to 25 Hz followed by median filtering (a filter length of 11 was found suitable). Whenever the difference between the original and median-filtered signals exceeds a certain threshold value, here set to half the standard deviation of the signal, the original samples are replaced by the median value of the neighboring samples.

In a few patients, short gaps (\<1 s) with missing samples occurred due to uncontrolled movements of the patients during acquisition. Rather than excluding these recordings from analysis, interpolation based on AR signal modeling was used to fill in the gaps. This method estimates the AR coefficients from the segment preceding the gap and then uses the coefficients to forward predict the signal across the missing samples. The same process is repeated for the segment that follows the gap using instead backward signal extrapolation. The gap of missing samples is then replaced by a crossfaded version of the two extrapolated values, using the following window[@CR8],[@CR20]$$\documentclass[12pt]{minimal}
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Finally, as the respiratory frequency does not exceed 0.5 Hz, the respiratory flow signals are decimated to 1 Hz, using appropriate low-pass filtering prior to downsampling. The decimation operation preserves the spectral information of interest, and ensures that AR modeling is not performed on an oversampled signal.[@CR21]

Breathing Pattern Characterization {#Sec5}
----------------------------------

The respiratory pattern characterization is based on the envelope of the respiratory flow signal, and thus contrasts previously described methods which are based on a sliding time window in which the amplitude, energy, or entropy are computed.[@CR10],[@CR12] For example, the normalized average Shannon energy, named as Shannon envelope, is a well-known technique which evaluates the average Shannon energy in successive signal segments. Nevertheless, there is a well-known technique[@CR21] based on the Hilbert transform (a 90-degree phase shifter) which extracts the envelope without the need of a sliding window. Figure [2](#Fig2){ref-type="fig"} shows as an example of the preprocessed respiratory flow signal and the envelope of a PB patient. Considering the properties and performance of each envelope detection method, we choose the one based on Hilbert transform to extract the envelope of the respiratory flow signal.FIGURE 2(a) Original flow signal, (b) preprocessed flow signal and its envelope, of a patient with PB pattern
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Due to the oscillatory character of respiratory flow signals, AR modeling is here employed for spectral analysis. The mean value of the envelope is subtracted and AR modeling is performed on the envelope signal. It is essential to have high spectral resolution in the vicinity of the modulation peak, and therefore the following order selection procedure was adopted. First, the optimum order was determined in each subject using the minimum description length criterion.[@CR19] Then, the maximum of the resulting model order estimates was selected and used as global model order in the subsequent signal analysis. We apply the Ljung--Box statistical test to prove the whiteness of the prediction error.

Parameter Extraction {#Sec6}
--------------------

Certain spectral parameters are extracted from the DB defined by the frequency interval (Δ~*f*~) centered at the modulation frequency peak (*f*~p~) (Table [1](#Tab1){ref-type="table"}). Figure [3](#Fig3){ref-type="fig"} shows the spectral parameters involve the power (*P*), right side power (*P*~R~), and left side power (*P*~L~) of the DB.TABLE 1Spectral parameters*P*Power in the DB\[*f*~p~ − Δ~*f*~/2, *f*~p~ + Δ~*f*~/2\]*P*~R~Power in the "right band"\[*f*~p~, *f*~p~ + Δ~*f*~/2\]*P*~L~Power in the "left band"\[*f*~p~ − Δ~*f*~/2, *f*~p~\]*f*~p~, frequency peak; Δ~*f*~ frequency intervalFIGURE 3Spectral parameters extracted from the DB with a bandwidth of Δ~*f*~ = 0.02 Hz

Within the 61 subjects of this study, the respiratory frequency is found to range from 0.2 to 0.4 Hz, whereas the modulation frequency ranged from 0.01 to 0.04 Hz. Consequently, the modulating frequency peak (*f*~p~) is searched for an interval ranging from 0.005 to 0.05 Hz, i.e., slightly larger than the range of the modulation frequency. Having studied the frequency peaks presented by all subjects of the database, the frequency interval is fixed to Δ~*f*~ = 0.02 Hz. Figure [4](#Fig4){ref-type="fig"} illustrates the different DBs for three CHF patients with different breathing patterns (CSR, PB without apnea, nPB) and a healthy subject.FIGURE 4DB of a CSR patient, a PB patient without apnea, a nPB patient, and a healthy subject

Data Analysis {#Sec7}
-------------

The accuracy of our pattern characterization is evaluated in terms of the following three classification problems: CHF patients vs. healthy subjects, nPB patients vs. healthy subjects, and CHF patients being either PB or nPB.

First, the statistical significance of the above-mentioned parameters derived from the DB is studied by the Mann--Whitney test. Next, a parameter selection process is implemented over the statistically significant parameters in order to select the most relevant subset (see Table [2](#Tab2){ref-type="table"}). Leave-one-out cross-validation technique is applied to the limited number of CHF patients (26 CHF patients and 35 healthy subjects). Only the most discriminative parameter is selected for each classification.TABLE 2*p*-Value of the statistically most significant parameters, for each classification*p*-ValueCHF vs. healthynPB-CHF vs. healthyPB vs. nPB (CHF)*P*4.3 × 10^−9^7.3 × 10^−7^6.8 × 10^−4^*P*~R~1.3 × 10^−8^2.4 × 10^−6^4.6 × 10^−4^*P*~L~3.2 × 10^−9^5.2 × 10^−7^1.4 × 10^−3^

Results {#Sec8}
=======

Examples {#Sec9}
--------

The global AR model order was found to be 4 when the above-mentioned selection procedure was applied. Applying the Ljung--Box test, the residuals of all 61 signals were found to be whitened by the global AR model. The present method is illustrated in Figs. [5](#Fig5){ref-type="fig"}--[8](#Fig8){ref-type="fig"} with examples taken from CSR, PB, nPB patients, and from a healthy subject. Figures [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"} show that the PSDs of CSR and PB patients exhibit a clear frequency peak in the interval 0.005--0.03 Hz. It is also obvious that respiratory modulation is more pronounced in the CSR patient than in the PB patient. As expected, the nPB patient and the healthy subject largely lack such modulation as the spectral peaks in this interval are much smaller (see Figs. [7](#Fig7){ref-type="fig"} and [8](#Fig8){ref-type="fig"}, respectively).FIGURE 5(a) The preprocessed flow signal and its envelope and (b) the PSD of a patient with CSR patternFIGURE 6(a) The preprocessed flow signal and its envelope and (b) the PSD of a PB patient without apnea patternFIGURE 7(a) The preprocessed flow signal and its envelope and (b) the PSD of an nPB patientFIGURE 8(a) The preprocessed flow signal and its envelope and (b) the PSD of a healthy subject

Performance Evaluation {#Sec10}
----------------------

Table [3](#Tab3){ref-type="table"} summarizes the results obtained with the most discriminant parameter for each of the three classification tasks.TABLE 3Sensitivity (*Sn*), specificity (*Sp*), and total accuracy (*Acc*), obtained with the best parameter for each classification with leave-one-out cross-validation techniqueClassificationParameter*Sn* (%)*Sp* (%)*Acc* (%)CHF vs. healthy*P*85.285.785.5nPB-CHF vs. Healthy*P*~L~84.285.785.2PB vs. nPB (CHF)*P*~R~75.088.984.6

The ROC curves of the statistically most significant parameters are studied so as to compare their performance in each classification. Table [4](#Tab4){ref-type="table"} presents the area under the curve (AUC) obtained with each parameter classifying different respiratory patterns. The AUC values validate the results obtained in all classifications with leave-one-out cross-validation technique. As expected, similar performance is obtained for the power-related parameters.TABLE 4ROC area*p*-ValueCHF vs. healthy (%)nPB-CHF vs. healthy (%)PB vs. nPB (CHF) (%)*P*93.891.192.1*P*~R~92.489.293.4*P*~L~94.191.789.5

Discussion {#Sec11}
==========

This article introduces envelope-based respiratory pattern characterization in CHF patients, used to quantify periodicity through spectral analysis. Our previous studies[@CR5],[@CR6] show that respiratory periodicity could be detected from the envelope of the flow signal using time--frequency analysis and employed for discriminating respiratory patterns in CHF patients. This article extends our previous work by investigating various envelope-based spectral parameters for identification of different respiratory patterns in CHF patients. It should be noted that the present approach to classification only involves one single parameter instead of three as our previous studies did.[@CR5],[@CR6]

An advantage of the method is that outlier removal conditions the respiratory flow signals for robust envelope extraction. Although different methods have been developed to take out the respiratory flow envelope,[@CR10] the one based on the Hilbert transform has presented good results and is the most efficient in terms of computational cost. Moreover, it does not require any normalization procedure which some of the other envelope extraction methods do.

The analysis of the respiratory flow signal provides a non-invasive tool to assess the autonomic nervous system influence on the respiratory pattern. Out of the established clinical predictors or linear HRV measures, the characterization of the respiratory flow signal envelope provides prediction markers to study the condition of CHF patients.

The main goal of this study is to characterize respiratory patterns that derive from PB and nPB patients, in order to identify different patterns and subsequently predict the condition of CHF patients. Both patient groups exhibit various degrees of periodicity depending on their condition, whereas healthy subjects have no pronounced periodicity. This observation is reflected by the parameter *P* which decreases proportionally to the periodicity of the pattern. Due to their lack of modulation peak the healthy subjects show the smallest values for this parameter, providing promising results for discrimination, i.e., CHF vs. healthy 85.5%, and nPB vs. healthy 85.2%, despite the fact that nPB patients and healthy subjects present apparently similar respiratory patterns. The power of the right DB provided the best results when classifying PB and nPB breathing patterns into CHF patients. The ROC curves validate the results obtained when identifying different respiratory patterns.

The small size of the dataset is a limitation of this study, and therefore the significance of the results, though promising, needs to be further established on a larger set. As a consequence of the small size, it was decided to only investigate the performance of single-parameter linear classification.

The extracted parameters characterize the respiratory pattern of these patients, and suggest that PB patterns are related to the patients' condition. However, more research is needed to study the relevance of the information provided by these periodic respiratory patterns with respect to what can be extracted using the traditional clinical indices.

Conclusions {#Sec12}
===========

In this study, the respiratory flow envelope signal analysis is proposed for the characterization of respiratory flow signal patterns. Some spectral parameters are used to identify different respiratory patterns and classify CHF patients with different conditions and healthy subjects. Power-related parameters provide the best discrimination results between different respiratory patterns. Of the most discriminating parameters, the power of the modulation peak provided an accuracy of 85.5 and 85.2% classifying CHF patients vs. healthy subjects, and nPB patients vs. healthy subjects, and the power of the right DB showed an 84.6% of well-classified patients in an internal CHF patient classification between PB and nPB patterns. These results suggest that the method can be a useful tool to characterize different respiratory patterns in CHF patients and healthy subjects.
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